St. Luke's Cancer Institute: Boise — Boise, Idaho

St. Luke's Cancer Institute: Boise is a clinical research site located in Boise, Idaho, United States 83712.

Crixeo Clinical Trials Trust Score: 15/100 (FAILING). This profile has not yet been claimed by the site owner.

St. Luke's Cancer Institute: Boise has participated in 5 clinical trials with 5 currently active.

Therapeutic areas: Breast Cancer, Metastatic Non-small Cell Lung Cancer With MTAP Deletion, Triple Negative Breast Neoplasms.

Sponsors: Pfizer, Bristol-Myers Squibb, Merck Sharp & Dohme LLC.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Boise

Browse all research sites in Idaho · View every site in Boise

Sponsor Feasibility Report

Trust Score: 15/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for St. Luke's Cancer Institute: Boise?

St. Luke's Cancer Institute: Boise has a Crixeo Trust Score of 15/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has St. Luke's Cancer Institute: Boise conducted?

St. Luke's Cancer Institute: Boise has 5 clinical trials on record, with 5 currently active. Their work covers Breast Cancer, Metastatic Non-small Cell Lung Cancer With MTAP Deletion, Triple Negative Breast Neoplasms.

Is St. Luke's Cancer Institute: Boise accredited by Crixeo Clinical Trials?

St. Luke's Cancer Institute: Boise has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about St. Luke's Cancer Institute: Boise?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.